Latest Private Placement News

NH3 Clean Energy has initiated the FEED phase for its WAH2 clean ammonia project, securing key partnerships and government support while raising $4 million to fuel development.

Theta Gold Mines has commenced bulk earthworks at its flagship TGME gold project in South Africa and secured nearly US$40 million in combined equity and debt funding, marking a pivotal step toward production.

SportsHero Limited has inked a pivotal two-year distribution agreement with PLDT Inc in the Philippines, raised $1.65 million through a private placement, and broadened its mobile gaming footprint across Southeast Asia with new content partnerships.

Sarytogan Graphite Limited reports strong progress in graphite and copper exploration, securing key DFS contracts and a $3.6 million placement to advance its flagship projects.

Globe Metals & Mining advances its Kanyika Niobium Project with a regulatory extension, licence expansion to new critical minerals, and a significant capital raise, positioning the company for its next development phase.

Chilwa Minerals has confirmed elevated rare earth and heavy mineral sands resources in Malawi, progressing exploration and metallurgical studies alongside a $4.1 million capital raise and strategic logistics talks.

Assetora Limited has raised $2 million through a private placement with CardioLink Pty Ltd, aiming to fuel its platform expansion and product development.

IperionX has boosted titanium powder production capacity by 60% and secured US$75 million in Department of War funding to scale up to 1,400 tonnes per annum by 2027, aiming to become the largest and lowest-cost US titanium producer.

CuFe Ltd has announced a dramatic 400% increase in contained copper at its Gecko project, alongside an upgraded Orlando resource and a $5.4 million capital raise to advance its Tennant Creek development plans.

Assetora Limited has reopened its flagship fund under a new name, secured a $3 million strategic investment, and reported its first positive operating cashflow since adopting its fund-management model.

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.